3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN

NCT01822652 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

GENETIC: iC9-GD2 T Cells - frozen
GENETIC: iC9-GD2 T Cells - fresh
DRUG: Cytoxan
DRUG: Fludara
DRUG: Keytruda
GENETIC: iC9-GD2 T cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]